Authors



Esin Izat, Beghou Consulting

Latest:

Navigating the patient journey after rare disease diagnosis

Commercial teams can prepare for overcoming predictable hurdles


Arthur G. Cook, ZS Associates

Latest:

Forecasting for the Pharmaceutical Industry

The second edition of an essential business planner's library


Sean McCarthy

Latest:

Strategies for effective patient services programs

Addressing continued hurdles in patient adherence


By Sumeet Singh, Five Rivers RX

Latest:

The current state of suspicious- order monitoring

DEA’s manufacturer and distributor data-collection requirements are changing


Heather Morel

Latest:

Smoothing the Path to Drug Safety

REMS programs need to address stakeholder usability



Angelo De Palma, PhD

Latest:

Feds Elevate Comparative Effectiveness to Address Future Healthcare Development

Evaluating medicine and healthcare by their outcomes is now an NIH priority


Robert Califf, MD

Latest:

Laying the foundation for a national system for evidence generation

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis



Desmond Hunt, PhD

Latest:

Complex supply chains demand a holistic approach to protect patients

The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity


Lindsay Duncan, Cegedim Dendrite

Latest:

Look for Flexibility In Your CRM or SFA System

Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?



Rubik Angelo Barar, Rajat Saxena

Latest:

Vaccine growth spurs device, contract-services markets

A double-digit growth rate through 2024 means boom times for drug-delivery devices and for contract manufacturing services


Dusty Tenney, Stirling UltraCold

Latest:

Meeting the challenges of rapid Covid-19 vaccine cold chain deployment

Ultralow temperatures require a revision of vaccine distribution technology


Don Hannaford, Levick Strategic Communications

Latest:

Transparency Is the Solution to the Medical-Journal 'Ghostwriting' Controversy

Drug companies should keep a goal of effective communications as the priority in medical publications


General Manager of UL Compliance to Performance

Latest:

Managing employee training at the enterprise level

The case for a single enterprise-wide learning management system


Bob Celeste, RCG Partners

Latest:

Does healthcare benefit from a unified approach to item-level serialization and UDI?

"If we had asked them, they would have asked for faster horses." ~ Henry Ford


Paul Keckley, Deloitte Center for Health Solutions

Latest:

Deloitte 2010 Survey of Health Care Consumers

More personal control over healthcare and the desire for more access to information drive consumer attitudes



Chris Cobourn

Latest:

Lessons learned on bona fide service fees and fair market value-is there a 'right answer'?

Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial


Steve Stefano

Latest:

Specialty pharmaceuticals demand integrated patient and prescriber approaches

True 'market access' should involve coordinated approaches to patients and their healthcare providers


John Still, PharmaMetrics Inc.

Latest:

Finding the value in outsourced contract administration

The growing complexity of managed-markets contract support makes outsourcing a near-necessity for Small Pharma, and a better option for Big Pharma


Kevin Lawler, Pelican BioThermal

Latest:

2020 Cold Chain Forecast

Ushering in the Next Decade of Change


Lesley Kristeff, iGPS LLC

Latest:

Making Pallets a Supply Chain Asset Instead of an Unrecoverable Cost

Recent product contamination incidents are highlighting the importance of having reliably clean pallets for warehousing and shipping


By Pharmaceutical Commerce Staff

Latest:

Pacira BioSciences Announces FDA Approval of Expanded Indications for Exparel

Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.


Executive Chairman, Zephyr Health

Latest:

Powering up medical affairs

Technology is enabling more resources to reach the medical 
affairs teams—in a compliant manner


By Mike Elliot, Custom Vault Corp.

Latest:

Storing controlled substances safely and efficiently

Good design of vaults and cages for DEA-regulated materials calls for meeting regulatory requirements while accommodating operational practices


Kyle Forcier

Latest:

A 340B Navigation Guide for Pharmaceutical Manufacturers

How drugmakers can navigate the program’s pricing challenges and regulatory developments.


By Rohit Sood, Campbell Alliance

Latest:

Life Cycle Management Without Borders

Taking a market-by-market approach to maximizing value after loss of exclusivity

© 2025 MJH Life Sciences

All rights reserved.